Gastrointestinal Cancer News & Features
Fecal immunochemical testing screening for colorectal cancer demonstrated a significant reduction in mortality.
In the update, authors summarize 2014 studies that are highly relevant to gastroenterology, including esophageal diseases, pancreatic cancer, and colorectal cancer.
Patients with gastrointestinal stromal tumors (GIST) have a higher risk of developing additional malignancies before and after diagnosis.
A new study focuses on survival outcomes of patients with locally advanced esophageal cancer (LAEC) beyond the 5-year mark.
Taking aspirin regularly may help prevent gastrointestinal cancers, a new study suggests, with the greater benefit seen when taking it over many years.
Gastrointestinal Cancer Clinical Trials
- Growing up with cancer: Understanding the challenges to adolescents and young adults (AYAs) coping with cancer
- Navigators have a key role in using genetics and genomics for cancer risk identification
- Using the navigation process to improve both your program and your patient outcomes
- Pilot program coordinates palliative care and support for rural communities
- Composing a CoC-compliant community health needs assessment (CHNA)
- Survivorship care plans: The shift back to primary care
- Scientists identify key to preventing metastatic breast cancer
- Noninvasive colon cancer screening promising for African Americans
- Cancer and intimate partner violence: Could you tell if one of your patients is a victim?
- Blood test detects breast cancer metastasis early
- Comorbid conditions associated with worse lung cancer survival
- Benefits found for screening colonoscopies of higher quality
- High-grade cervical lesions declining in young women
- Early relapse of follicular lymphoma may increase risk of death
- Study identifies perception gap in incidence, impact of CINV/RINV
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|